These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25065457)

  • 1. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency.
    Suzuki J; Connery HS; Ellison TV; Renner JA
    Am J Addict; 2014; 23(6):618-22. PubMed ID: 25065457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.
    Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D
    Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs.
    Suzuki J; Ellison TV; Connery HS; Surber C; Renner JA
    Acad Psychiatry; 2016 Jun; 40(3):498-502. PubMed ID: 26017618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients.
    Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A
    J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
    Peterson LE; Morgan ZJ; Eden AR
    J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends In Buprenorphine Prescribing By Physician Specialty.
    Wen H; Borders TF; Cummings JR
    Health Aff (Millwood); 2019 Jan; 38(1):24-28. PubMed ID: 30615523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to primary care physicians prescribing buprenorphine.
    Hutchinson E; Catlin M; Andrilla CH; Baldwin LM; Rosenblatt RA
    Ann Fam Med; 2014; 12(2):128-33. PubMed ID: 24615308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steps physicians report taking to reduce diversion of buprenorphine.
    Yang A; Arfken CL; Johanson CE
    Am J Addict; 2013; 22(3):184-7. PubMed ID: 23617857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice Predictors of Buprenorphine Prescribing by Family Physicians.
    Peterson LE; Morgan ZJ; Borders TF
    J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.
    Mahal JJ; Bijur P; Sloma A; Starrels J; Lu T
    West J Emerg Med; 2024 May; 25(3):303-311. PubMed ID: 38801034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice.
    Pytell JD; Buresh ME; Graddy R
    Addict Sci Clin Pract; 2019 Dec; 14(1):46. PubMed ID: 31856915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists.
    Thomas CP; Reif S; Haq S; Wallack SS; Hoyt A; Ritter GA
    Psychiatr Serv; 2008 Aug; 59(8):909-16. PubMed ID: 18678689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternity Care and Buprenorphine Prescribing in New Family Physicians.
    Louis JS; Eden AR; Morgan ZJ; Barreto TW; Peterson LE; Phillips RL
    Ann Fam Med; 2020 Mar; 18(2):156-158. PubMed ID: 32152020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
    McBain RK; Dick A; Sorbero M; Stein BD
    Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
    [No Abstract]   [Full Text] [Related]  

  • 19. Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.
    James JR; Gordon LM; Klein JW; Merrill JO; Tsui JI
    Subst Abus; 2019; 40(1):11-13. PubMed ID: 29578857
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
    Pan K; Silver S; Davis C
    Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.